Report Categories
View AllRecent Articles
View All
PYXS Pyxis Oncology beats Q4 2025 loss estimates but shares shed 235 percent amid weak investor reaction
HIFS Hingham posts Q3 2025 EPS of 386 shares dip 226 following quarterly earnings release
Is ITT ITT a once in a decade opportunity Edges Lower 20260508
What Cadiz CDZIP does better than 90 of companies In Focus 20260505